PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
5.20
+0.46 (9.70%)
At close: Aug 14, 2026, 4:00 PM EDT
5.27
+0.07 (1.35%)
After-hours: Aug 14, 2026, 7:34 PM EDT
PAVmed Employees
PAVmed had 41 employees as of December 31, 2025. The number of employees increased by 2 or 5.13% compared to the previous year.
Employees
41
Change (1Y)
2
Growth (1Y)
5.13%
Revenue / Employee
$2,732
Profits / Employee
-$255,195
Market Cap
37.23M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 41 | 2 | 5.13% | 41 | 0 |
| Dec 31, 2024 | 39 | -68 | -63.55% | 39 | 0 |
| Dec 31, 2023 | 107 | -17 | -13.71% | 107 | 0 |
| Dec 31, 2022 | 124 | 35 | 39.33% | 124 | 0 |
| Dec 31, 2021 | 89 | 64 | 256.00% | 89 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Accuray | 990 |
| Nortech Systems | 713 |
| TELA Bio | 218 |
| Xtant Medical Holdings | 151 |
| Baird Medical Investment Holdings | 146 |
| InspireMD | 127 |
| Pulsenmore | 71 |
| SANUWAVE Health | 55 |
PAVM News
- 15 hours ago - PAVmed Earnings Call Transcript: Q2 2026 - Transcripts
- 15 hours ago - PAVmed Quarterly report: Q2 2026 - Filings
- 15 hours ago - PAVmed Earnings release: Q2 2026 - Filings
- 15 hours ago - PAVmed Slides: Q2 2026 - Filings
- 16 hours ago - PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results - PRNewsWire
- 1 day ago - Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results - PRNewsWire
- 9 days ago - Lucid announces Concert issued positive coverage policy for EsoGuard test - TheFly
- 9 days ago - Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test - PRNewsWire